Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02248402
What this trial is testing

Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Chonnam National University Hospital 15
Testing effectiveness (Phase 2)WithdrawnNCT01055301
What this trial is testing

S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaPlasma Cell Myeloma
SWOG Cancer Research Network
Not applicableEnded earlyNCT00748631
What this trial is testing

Treatment of Malignant Vertebral Fractures With Percutaneous Balloon Kyphoplasty.

Who this might be right for
Vertebral FractureMultiple MyelomaOsteolytic Metastases
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Study completedNCT01753453
What this trial is testing

An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem Cells

Who this might be right for
Multiple Myeloma
Sanofi 23
Early research (Phase 1)Looking for participantsNCT07333430
What this trial is testing

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (MM)
Hadassah Medical Organization 60
Early research (Phase 1)Ended earlyNCT03015792
What this trial is testing

Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 18
Early research (Phase 1)Study completedNCT03111992
What this trial is testing

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 26
Not applicableUnknownNCT05381077
What this trial is testing

Evaluation of Whole Body Examination by MRI Integrating the "Zero Time Eco" Sequence (ZTE, Pseudo-CT) for the Detection of Bone Lesions in Multiple Myeloma: Comparison With Pet / CT and Whole Body Scanner

Who this might be right for
Multiple MyelomaBone Metastases
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 30
Early research (Phase 1)Study completedNCT00545519
What this trial is testing

A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma

Who this might be right for
Relapsed Or Refractory Multiple Myeloma
Washington University School of Medicine 6
Testing effectiveness (Phase 2)Ended earlyNCT02756728
What this trial is testing

A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma

Who this might be right for
Multiple Myeloma
BioInvent International AB 5
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT05243212
What this trial is testing

Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple Myeloma
Sheba Medical Center 75
Very early researchActive Not RecruitingNCT05302648
What this trial is testing

To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MM

Who this might be right for
Multiple Myeloma
Hrain Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT02586038
What this trial is testing

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Who this might be right for
Multiple Myeloma
Mario Boccadoro 175
Early research (Phase 1)Study completedNCT01727778
What this trial is testing

Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Drug Safety
Patrys Ltd. 12
Not applicableStudy completedNCT00014235
What this trial is testing

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia/Transient Myeloproliferative DisorderAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+74 more
Fred Hutchinson Cancer Center 160
Testing effectiveness (Phase 2)Study completedNCT01212952
What this trial is testing

Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
Mayo Clinic 50
Early research (Phase 1)Ended earlyNCT05065047
What this trial is testing

Belantamab Mafadotin Maintenance Therapy After Salvage Autologous Hematopoietic Cell Transplantation in Patients With Relapse Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 6
Not applicableStudy completedNCT05212233
What this trial is testing

Financial Difficulty in Patients With Blood Cancer

Who this might be right for
Chronic Lymphocytic LeukemiaMultiple Myeloma
UNC Lineberger Comprehensive Cancer Center 218
Not applicableActive Not RecruitingNCT06323447
What this trial is testing

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

Who this might be right for
Diffuse Large B Cell LymphomaMultiple Myeloma
Leuko Labs, Inc. 210
Next Page